Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

INSANE: Neuronetics | Rare Historical Photos

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Benzinga · Nov 18, 2025

This Penny Stock Is Up 170% in 2025 and Analysts Think It Can Rally Further From Here

Neuronetics is poised for further gains with robust fundamentals and breakthrough innovations

Barchart · Mar 25, 2025

Bigbear.Ai and 2 More Penny Stocks Insiders Are Buying

Heavy insider buying has pinged the radar on these three penny stocks lately, but are they worth adding to your portfolio this June?

Barchart · Jun 12, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap: Neuronetics Q1 Earnings

Neuronetics (NASDAQ:STIM) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga · May 12, 2022

Neuronetics Earnings Conference Call Is Coming Up, Here's What You Need To Know

Neuronetics (NASDAQ:STIM) will host a conference call at 08:30 AM ET on May 12, 2022, to discuss Q1 2022 earnings results. How to Attend Neuronetics (STIM) Conference Call Follow this link to access the live webcast.

Benzinga · Apr 29, 2022

Executives Buy Around $1M Of 4 Penny Stocks

The ISM services PMI rose to 58.3 in March from 56.5 in the previous month. Investors, meanwhile, focused on some notable insider trades.

Benzinga · Apr 5, 2022

Neuronetics's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q4, Neuronetics's (NASDAQ:STIM) reported sales totaled $15.02 million. Despite a 6.32% increase in earnings, the company posted a loss of $7.64 million.

Benzinga · Mar 10, 2022

Read news from The Economist, FT, and more,
with one subscription

Neuronetics Posts Better Than Expected Q4 Results Despite Lower NeuroStar Therapy System Sales

Neuronetics Inc (NASDAQ: STIM) reported

Benzinga · Mar 8, 2022

Recap: Neuronetics Q4 Earnings

Neuronetics (NASDAQ:STIM) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 8, 2022

Preview: Neuronetics's Earnings

Neuronetics (NASDAQ:STIM) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts estimate that Neuronetics will report an earnings per share (EPS) of $-0.32.

Benzinga · Mar 7, 2022

Coverage From

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Health Care

3,420 stories

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.